Urology Devices
The U.S. urology device market continues to grow due to the increasing prevalence of urinary disorders, kidney diseases, and minimally invasive treatment options. Our research delivers in-depth insights into market trends, technology advancements, competitive landscape, and growth prospects.
The U.S. Ambulatory Urology Devices Market is projected to expand from USD 5.36 billion in 2026 to USD 9.29 billion by 2032 at a 9.65% CAGR. Growth is driven by rapid surgical migration into ambulatory surgery centers, rising prevalence of benign prostatic hyperplasia and urolithiasis, and operational shifts toward single-use digital ureteroscopy and office-based ablative therapies.
Read Report Details
The U.S. Digital Urology Devices Market is projected to grow from USD 6.05 billion in 2026 to USD 11.85 billion by 2032, exhibiting an 11.85% CAGR. Expansion is driven by the rapid adoption of single-use digital ureteroscopes, robotic-assisted surgical platforms, AI-enabled diagnostics, and migrating procedural volumes toward ambulatory surgical centers across high-burden stone and oncology populations.
Read Report Details
The U.S. AI-enabled urology devices market is projected to expand from USD 3.08 billion in 2026 to USD 7.82 billion by 2032, registering a 16.80% CAGR. Growth is driven by the rapid adoption of robotic-assisted surgical systems, computer vision endoscopy, and automated laser lithotripsy across hospitals and ambulatory surgery centers, standardizing surgical precision and improving patient outcomes nationwide.
Read Report Details
The U.S. smart urology devices market is projected to expand from USD 6.94 billion in 2026 to USD 13.88 billion by 2032, recording a 12.25% CAGR. Growth is propelled by escalating cases of BPH and urolithiasis, rapid clinical migration to ambulatory surgery centers, widespread adoption of single-use digital endoscopes, and breakthroughs in surgical robotics and smart neuromodulation ecosystems.
Read Report Details
The U.S. Reusable Urology Devices Market is experiencing robust growth, driven by an aging demographic, rising urolithiasis prevalence, and the rapid migration of procedures to ambulatory surgery centers. Transitioning to 4K digital endoscopy and thulium fiber lasers, healthcare providers are investing heavily in durable, reprocess able capital equipment to optimize cost-per-case metrics and strictly manage infection control.
Read Report Details
The U.S. single-use urology devices market is projected to reach USD 6.42 billion by 2032, advancing at an 11.45% CAGR from USD 3.36 billion in 2026. Growth is driven by rapid clinical migration toward disposable flexible ureteroscopes and cystoscopes, stringent infection-control standards, elevated kidney stone intervention rates, and rising surgical case volumes in ambulatory surgery centers.
Read Report Details
The U.S. Disposable Urology Devices Market is projected to surge from USD 5.12 billion in 2026 to USD 8.96 billion by 2032, advancing at a 9.78% CAGR. Growth is propelled by institutional mandates for cross-contamination elimination, rising kidney stone and BPH prevalence, rapid endourology migration into ambulatory surgery centers, and expanding Medicare reimbursement for sterile hydrophilic catheters.
Read Report Details
The U.S. Endourology Devices Market is projected to expand from USD 2.70 billion in 2026 to USD 4.35 billion by 2032, recording an 8.27% CAGR. Growth is driven by escalating urolithiasis prevalence across the U.S. Stone Belt, rapid procedure migration to ambulatory surgery centers, widespread adoption of single-use digital ureteroscopes, and high-frequency thulium laser lithotripsy systems.
Read Report Details
The U.S. Minimally Invasive Urology Devices Market is projected to grow from USD 4.65 billion in 2026 to USD 7.42 billion by 2032, exhibiting an 8.10% CAGR. Growth is fueled by high kidney stone prevalence, rapid ambulatory migration, expanding single-use digital endoscopy adoption, advanced thulium fiber laser systems, and minimally invasive robotic interventions for benign prostatic hyperplasia and oncology.
Read Report Details
The U.S. Advanced Urology Devices Market is projected to grow from USD 6.48 billion in 2026 to USD 11.24 billion by 2032, advancing at a 9.62% CAGR. Market expansion is propelled by rapid surgical migration to ambulatory centers, conversion to sterile single-use digital ureteroscopes, adoption of high-power Thulium Fiber Lasers, robotic waterjet BPH ablation, and next-generation sacral neuromodulation implants.
Read Report Details